Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9310732 | Kidney International | 2005 | 11 Pages |
Abstract
PAI-1 can regulate TGF-β expression by binding to uPAR and activating the extracellular-regulated signal kinase (ERK)/MAPK pathway. Therefore, PAI-1 contributes to diabetic nephropathy by regulating TGF-β and renal ECM production and may be a therapeutic target in diabetic nephropathy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Susanne B. Nicholas, Elsa Aguiniga, Yuelan Ren, Jason Kim, Joyce Wong, Nalini Govindarajan, Masakuni Noda, Wei Wang, Yasuko Kawano, Alan Collins, Willa A. Hsueh,